Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Oct;30(5):257-63.
doi: 10.1111/j.1755-5922.2011.00280.x. Epub 2011 May 31.

Novel treatments for cardiovascular disease prevention

Mark D Huffman  1 , Deepak Bhatnagar
Affiliations
Review

Novel treatments for cardiovascular disease prevention

Mark D Huffman et al. Cardiovasc Ther. 2012 Oct.

Abstract

The purpose of this review is to describe novel pharmacologic and nonpharmacologic preventive therapies, as well as new strategies to improve delivery of available therapies. Cardiovascular disease (CVD) is the leading cause of death worldwide, and prevention plays a critical role in curbing the global epidemic. Despite available treatment for tobacco addiction, platelet inhibition, blood pressure, and lipid lowering for reduction of atherosclerotic disease, significant gaps in treatment of total CVD remain. We review a range of new preventive treatment options, including drugs for tobacco cessation, platelet/thrombotic inhibition, lipid- and blood pressure-lowering; nonpharmacologic options such as left atrial appendage closure devices and caloric restriction; and strategies such as fixed-dose combination drugs, laboratory screening for drug tailoring, and community-based prevention programs. CVD preventive research continues to evolve and provide clinicians and patients with novel pharmacologic and nonpharmacologic therapies, including new preventive strategies.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

We have no conflicts of interest to disclose.

References

    1. World Health Organization. Geneva, Switzerland: [5 September 2009]. Disease and injury regional estimates for 2004. Available from: http://www.who.int/healthinfo/global_burden_disease/estimates_regional/e....
    1. Mirzaei M, Truswell AS, Taylor R, Leeder SR. Coronary heart disease epidemics: Not all the same. Heart. 2009;95:740–746. - PubMed
    1. United States Food and Drug Administration. FDA approves novel medication for smoking cessation. [10 June 2010];2006 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108651....
    1. Gonzales D, Rennard SI, Nides M, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. JAMA. 2006;296:47–55. - PubMed
    1. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: A randomized trial. Circulation. 2010;121:221–229. - PMC - PubMed

Publication types

MeSH terms